Pages that link to "Item:Q827694"
From MaRDI portal
The following pages link to Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer (Q827694):
Displaying 5 items.
- Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections (Q745130) (← links)
- Optimisation of anti-cancer peptide vaccines to preferentially elicit high-avidity T cells (Q2288459) (← links)
- On a discrete model of tumour–immune system interactions with blockade of immune checkpoints (Q5037845) (← links)
- A Mathematical Model of TCR-T Cell Therapy for Cervical Cancer (Q6496561) (← links)
- Mathematical model for IL-2-based cancer immunotherapy (Q6566666) (← links)